Sale

Cardiopulmonary Bypass Equipment Market

Global Cardiopulmonary Bypass Equipment Market Size, Share: By Product: Heart–Lung Machines, Oxygenators, Autotransfusion Systems, Others; By Application: Cardiovascular, Respiratory, Hemodialysis, Others; By Type: Single Roller Pump, Double Roller Pump; By End User: Hospitals, Others; Regional Analysis; Supplier Landscape; 2024-2032

Global Cardiopulmonary Bypass Equipment Market Size

The global cardiopulmonary bypass equipment market was valued at USD 356 million in 2023, driven by increasing incidence of cardiopulmonary conditions across the globe. The market is expected to grow at a CAGR of 4.24% during the forecast period of 2024-2032, with the values likely to reach USD 517.6 million by 2032.

 

Global Cardiopulmonary Bypass Equipment Market Outlook

  • The demand for cardiopulmonary bypass equipment is on the rise, intended to combat rising the cardiopulmonary disease associated mortality rates. Approximately 1 in 13 individuals are affected with circulatory or heart diseases worldwide.
  • One of the major market trends includes advancements in technology contributing to better patient outcomes.
  • North America is likely to experience notable growth in the forecast period.

 

Global Cardiopulmonary Bypass Equipment Market Overview

Cardiopulmonary bypass is an equipment that temporarily takes over the function of the heart and lungs during a cardiac surgery by maintaining the circulation of blood and oxygen throughout the body. The equipment typically includes oxygenators, pumps, filters, and tubing. The market growth is also driven by an increasing preference for minimally invasive procedures, and technological advancements among others.

 

Global Cardiopulmonary Bypass Equipment Market Growth Drivers

Increasing Prevalence of Cardiopulmonary Diseases to Affect the Market Landscape Significantly

With rising incidence of cardiopulmonary conditions, the market has been witnessing an influx of new and innovative products to provide enhanced patient outcomes. According to World  Health Organization (WHO), approximately 17.9 million people died from cardiovascular diseases in 2019, which represents 32% of all global deaths. With the rise in aging population, WHO estimates that between 2015  and 2050, the proportion of the world's population aged above 60 years will nearly double from 12% to 22%. Since geriatric population is more susceptible to develop chronic conditions, the market value for cardiopulmonary bypass equipment is likely to grow.

 

Growth in Strategic Partnerships and Mergers to Meet Rising Cardiopulmonary Bypass Equipment Market Demand

In April 2024, NuvoAir  Medical partnered with Privia Medical Group to provide virtual-first care model and transform cardiopulmonary care. The partnership focused on leveraging NuvoAir's advanced digital health technologies to enhance the management of cardiopulmonary diseases, making healthcare more accessible and efficient. By integrating these technologies, the partnership aims to offer continuous, high-quality care outside conventional healthcare settings. The patients can benefit from real-time monitoring of their respiratory health, personalized treatment adjustments, and direct communication with healthcare providers, from wherever they are.

 

In July 2023, Inspira ™ Technologies entered into a collaboration agreement with Perfusion Solution, Inc. This collaboration involved combining Inspira™ Technologies' innovative oxygenation technology, INSPIRA™ ART100 product with Perfusion Solution's expertise in perfusion systems. Such collaborations are aimed at developing and refining solutions in order to improve patient outcomes during critical care and surgical procedures, propelling the market value in the forecast period.

 

Global Cardiopulmonary Bypass Equipment Market Trends

The market is witnessing several trends and developments to improve the current global scenario. Some of the notable trends are as follows:

 

Trends Impact
Increasing Prevalence of Cardiopulmonary Diseases The increase in burden for cardiopulmonary diseases worldwide is a primary driver for cardiopulmonary bypass equipment. With the increase in older adults, age related issues comprising heart conditions also increases. With lifestyle changes lacking physical activity, high stress levels and poor diet leads to conditions like hypertension, diabetes, and obesity. This leads to a significant decline in heart and gut health and can lead to coronary artery disease, arrythmia or heart attack.
Technological Advancements There is a shift towards integrating real-time monitoring systems and automation in cardiopulmonary bypass equipment. Such innovations provide safety and precision in procedures which offers better control to the surgeons during operations. Furthermore, the innovation in constructing smaller and more compact bypass machines is broadening the scope for minimally invasive surgeries.
Shift Toward Outpatient Cardiac Surgeries The adoption of minimally invasive surgical procedures has resulted in performing more surgeries in out-patient settings, thereby reducing prolonged hospitalization. Being economically advantageous, such settings are likely to boost the demand for cardiopulmonary bypass equipment.
Regulatory and Reimbursement Shifts The shift in insurance reimbursement policies and regulatory framework across different countries are impacting the market. Stringent regulations are enforced for efficacy and safety of medical devices including cardiopulmonary bypass machines. As a result, healthcare systems are prioritizing cost-effectiveness leading to reimbursement for cardiac procedures.

 

Global Cardiopulmonary Bypass Equipment Market Segmentation

Market Breakup by Product

  • Heart–Lung Machines
  • Oxygenators
  • Autotransfusion Systems
  • Others

 

Market Breakup by Application

  • Cardiovascular
  • Respiratory
  • Hemodialysis
  • Others

 

Market Breakup by Type

  • Single Roller Pump
  • Double Roller Pump

 

Market Breakup by End User

  • Hospitals
  • Specialty Clinics
  • Dialysis Centers
  • Ambulatory Surgery Centers

 

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

 

Global Cardiopulmonary Bypass Equipment Market Share

Heart-Lung Machines are Expected to Lead the Market Share Based on Product

Based on product, the market segmentation includes heart–lung machines, oxygenators, autotransfusion systems, and others. In cardiac surgeries these products are necessary to conduct cardiopulmonary bypass. Heart-lung machines are integral for bypass procedures and is expected to lead the market. This product allows surgeons to perform time consuming and complex surgeries by maintaining blood circulation without interrupting any organ function.

 

Autotransfusion systems are also gaining popularity, owing to its ability to reduce the need for blood transfusions as it allows the reinfusion of patients own blood during the procedure. This also minimizes the risk of blood-borne infections. Therefore, its adoption is rising attributed to its enhanced patient outcomes in surgical procedures where blood loss is significant.

 

By Type, Single Roller Pumps are Expected to Hold a Significant Market Value

Based on type, the market constitutes single roller pump and double roller pump. Single roller pumps are known for their simplicity and cost-effectiveness, majorly utilized in surgeries demanding shorter bypass durations. There are known for their reliability and affordability. This pump is accessible to a wide range of healthcare facilities from hospitals to clinics. Continuous advancements in functionality and design of single roller pump are aimed to reduce blood trauma and increase patient outcome.

 

On the other hand, double roller pump provides control and precision making it essential for time taking and complex surgeries. This segment is projected to grow as the demand for precision soars.

 

Global Cardiopulmonary Bypass Equipment Market Analysis by Region

The regional segment offers an insight into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North American market is expected to expand at a significant rate. This region is supported by access to advance healthcare and developed healthcare infrastructure.

 

Asia Pacific region is likely to witness the fastest growth rate, accredited to increasing improvements in the healthcare infrastructure and significant budget allocation by government to promote quality research and development in the medical domain. Awareness around cardiopulmonary health is also one of the factors expected to boost the market value of the region in the forecast period.

 

Leading Players in the Global Cardiopulmonary Bypass Equipment Market

The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

 

  • Medtronic PLC
  • LivaNova PLC
  • MAQUET Holding B.V. & Co. KG.
  • Terumo Corporation
  • Braile Biomedica Ltd
  • Tianjin Medical
  • Senko Medical Instrument Manufacturing Co. Ltd.
  • Abbott
  • Becton, Dickinson and Company
  • Beijing ZKSK Technology Co., Ltd.
  • Nipro Corporation
  • MicroPort Scientific Corporation
  • Precision Medical, Inc.
  • Zimmer Biomet Holdings, Inc.
  • Technowood Corporation

 

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product
  • Application
  • Type
  • End User
  • Region
Breakup by Product
  • Heart–Lung Machines
  • Oxygenators
  • Autotransfusion Systems
  • Others
Breakup by Application
  • Cardiovascular
  • Respiratory
  • Hemodialysis
  • Others
Breakup by Type
  • Single Roller Pump
  • Double Roller Pump
Breakup by End User
  • Hospitals
  • Specialty Clinics
  • Dialysis Centers
  • Ambulatory Surgery Centers
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Medtronic PLC
  • LivaNova PLC
  • MAQUET Holding B.V. & Co. KG.
  • Terumo Corporation
  • Braile Biomedica Ltd
  • Tianjin Medical
  • Senko Medical Instrument Manufacturing Co. Ltd.
  • Abbott 
  • Becton, Dickinson and Company 
  • Beijing ZKSK Technology Co., Ltd.
  • Nipro Corporation
  • MicroPort Scientific Corporation 
  • Precision Medical, Inc.
  • Zimmer Biomet Holdings, Inc.  
  • Technowood Corporation

 

Key Questions Answered in the Global Cardiopulmonary Bypass Equipment Market Report

  • What was the global cardiopulmonary bypass equipment market value in 2023?
  • What is the global cardiopulmonary bypass equipment market forecast outlook for 2024-2032?
  • What are the regional markets covered in the EMR report?
  • What is market segmentation based on product?
  • What is the market breakup based on type?
  • Who are the major end users in the market?
  • Where does cardiopulmonary bypass equipment find its application?
  • What are the major factors aiding the global cardiopulmonary bypass equipment market demand? 
  • How has the market performed so far and how is it anticipated to perform in the coming years?
  • What are the market's major drivers, opportunities, and restraints? 
  • Which regional market is expected to lead the market share in the forecast period? 
  • Which country is expected to experience expedited growth during the forecast period? 
  • How does the prevalence and incidence of cardiopulmonary diseases affect the market landscape?
  • What are the major global cardiopulmonary bypass equipment market trends?
  • How does the rise in the geriatric population impact the market size?
  • What product will dominate the market share? 
  • Which application area is expected to have a high market value in the coming years?
  • Which type segment will experience the highest demand in the market segment?
  • Who are the key players involved in the cardiopulmonary bypass equipment market?
  • What is patent landscape of the market?
  • What are the current unmet needs and challenges in the market?
  • How are partnerships, collaborations, mergers and acquisitions among the key market players shaping the market dynamics?

 

Cardiopulmonary Bypass Equipment Market Report Snapshots

Cardiopulmonary Bypass Equipment Market Size

Cardiopulmonary Bypass Equipment Market Growth

Cardiopulmonary Bypass Equipment Market Trends

Cardiopulmonary Bypass Equipment Market Share

Cardiopulmonary Bypass Equipment Market Regional Analysis

Cardiopulmonary Bypass Equipment Companies

 

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions
    1.3    Report Coverage – Key Segmentation and Scope 
    1.4    Research Methodology
2    Executive Summary
3    Global Cardiopulmonary Bypass Equipment Market Overview
 
    3.1    Global Cardiopulmonary Bypass Equipment Market Historical Value (2017-2023) 
    3.2    Global Cardiopulmonary Bypass Equipment Market Forecast Value (2024-2032)
4    Global Cardiopulmonary Bypass Equipment Market Landscape*
    4.1    Global Cardiopulmonary Bypass Equipment: Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Global Cardiopulmonary Bypass Equipment: Product Landscape
        4.2.1    Analysis by Product    
        4.2.2    Analysis by Application
5    Global Cardiopulmonary Bypass Equipment Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
        5.2.1    Strengths
        5.2.2    Weaknesses
        5.2.3    Opportunities
        5.2.4    Threats
    5.3    Porter’s Five Forces Model
        5.3.1    Bargaining Power of Suppliers
        5.3.2    Bargaining Power of Buyers
        5.3.3    Threat of New Entrants
        5.3.4    Threat of Substitutes
        5.3.5    Degree of Rivalry
    5.4    Key Demand Indicators 
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends  
    5.7    Value Chain Analysis
6    Global Cardiopulmonary Bypass Equipment Market Segmentation (2017-2032)
    6.1    Global Cardiopulmonary Bypass Equipment Market (2017-2032) by Product
        6.1.1    Market Overview
        6.1.2    Heart–Lung Machines
        6.1.3    Oxygenators
        6.1.4    Autotransfusion Systems
        6.1.5    Others
    6.2    Global Cardiopulmonary Bypass Equipment Market (2017-2032) by Application
        6.2.1    Market Overview
        6.2.2    Cardiovascular
        6.2.3    Respiratory
        6.2.4    Hemodialysis
        6.2.5    Others
    6.3    Global Cardiopulmonary Bypass Equipment Market (2017-2032) by Type
        6.3.1    Market Overview
        6.3.2    Single Roller Pump
        6.3.3    Double Roller Pump
    6.4    Global Cardiopulmonary Bypass Equipment Market (2017-2032) by End User
        6.4.1    Market Overview
        6.4.2    Hospitals
        6.4.3    Specialty Clinics
        6.4.4    Dialysis Centers
        6.4.5    Ambulatory Surgery Centers
    6.5    Global Cardiopulmonary Bypass Equipment Market (2017-2032) by Region
        6.5.1    Market Overview
        6.5.2    North America
        6.5.3    Europe 
        6.5.4    Asia Pacific
        6.5.5    Latin America
        6.5.6    Middle East and Africa
7    North America Cardiopulmonary Bypass Equipment Market (2017-2032)
    7.1    North America Cardiopulmonary Bypass Equipment Market (2017-2032) by Product
        7.1.1    Market Overview    
        7.1.2    Heart–Lung Machines
        7.1.3    Oxygenators
        7.1.4    Autotransfusion Systems
        7.1.5    Others
    7.2    North America Cardiopulmonary Bypass Equipment Market (2017-2032) by Application
        7.2.1    Market Overview
        7.2.2    Cardiovascular
        7.2.3    Respiratory
        7.2.4    Hemodialysis
        7.2.5    Others
    7.3    North America Cardiopulmonary Bypass Equipment Market (2017-2032) by Country
        7.3.1    United States of America
        7.3.2    Canada
8    Europe Cardiopulmonary Bypass Equipment Market (2017-2032)
    8.1    Europe Cardiopulmonary Bypass Equipment Market (2017-2032) by Product
        8.1.1    Market Overview    
        8.1.2    Heart–Lung Machines
        8.1.3    Oxygenators
        8.1.4    Autotransfusion Systems
        8.1.5    Others
    8.2    Europe Cardiopulmonary Bypass Equipment Market (2017-2032) by Application
        8.2.1    Market Overview
        8.2.2    Cardiovascular
        8.2.3    Respiratory
        8.2.4    Hemodialysis
        8.2.5    Others
    8.3    Europe Cardiopulmonary Bypass Equipment Market (2017-2032) by Country
        8.3.1    United Kingdom
        8.3.2    Germany
        8.3.3    France
        8.3.4    Italy
        8.3.5    Others
9    Asia Pacific Cardiopulmonary Bypass Equipment Market (2017-2032)
    9.1    Asia Pacific Cardiopulmonary Bypass Equipment Market (2017-2032) by Product
        9.1.1    Market Overview    
        9.1.2    Heart–Lung Machines
        9.1.3    Oxygenators
        9.1.4    Autotransfusion Systems
        9.1.5    Others
    9.2    Asia Pacific Cardiopulmonary Bypass Equipment Market (2017-2032) by Application
        9.2.1    Market Overview
        9.2.2    Cardiovascular
        9.2.3    Respiratory
        9.2.4    Hemodialysis
        9.2.5    Others
    9.3    Asia Pacific Cardiopulmonary Bypass Equipment Market (2017-2032) by Country
        9.3.1    China
        9.3.2    Japan
        9.3.3    India
        9.3.4    ASEAN
        9.3.5    Australia
        9.3.6    Others
10    Latin America Cardiopulmonary Bypass Equipment Market (2017-2032)
    10.1     Latin America Cardiopulmonary Bypass Equipment Market (2017-2032) by Product
        10.1.1    Market Overview    
        10.1.2    Heart–Lung Machines
        10.1.3    Oxygenators
        10.1.4    Autotransfusion Systems
        10.1.5    Others
    10.2    Latin America Cardiopulmonary Bypass Equipment Market (2017-2032) by Application
        10.2.1    Market Overview
        10.2.2    Cardiovascular
        10.2.3    Respiratory
        10.2.4    Hemodialysis
        10.2.5    Others
    10.3    Latin America Cardiopulmonary Bypass Equipment Market (2017-2032) by Country
        10.3.1    Brazil
        10.3.2    Argentina
        10.3.3    Mexico
        10.3.4    Others
11    Middle East and Africa Cardiopulmonary Bypass Equipment Market (2017-2032)
    11.1     Middle East and Africa Cardiopulmonary Bypass Equipment Market (2017-2032) by Product
        11.1.1    Market Overview    
        11.1.2    Heart–Lung Machines
        11.1.3    Oxygenators
        11.1.4    Autotransfusion Systems
        11.1.5    Others
    11.2    Middle East and Africa Cardiopulmonary Bypass Equipment Market (2017-2032) by Application
        11.2.1    Market Overview
        11.2.2    Cardiovascular
        11.2.3    Respiratory
        11.2.4    Hemodialysis
        11.2.5    Others
    11.3    Middle East and Africa Cardiopulmonary Bypass Equipment Market (2017-2032) by Country
        11.3.1    Saudi Arabia
        11.3.2    United Arab Emirates
        11.3.3    Nigeria
        11.3.4    South Africa
        11.3.5    Others
12    Regulatory Framework
    12.1     Regulatory Overview
        12.1.1    US FDA
        12.1.2    EU EMA
        12.1.3    INDIA CDSCO
        12.1.4    JAPAN PMDA
        12.1.5    Others
13    Patent Analysis
    13.1     Analysis by Type of Patent
    13.2     Analysis by Publication Year
    13.3     Analysis by Issuing Authority
    13.4     Analysis by Patent Age
    13.5     Analysis by CPC Analysis
    13.6     Analysis by Patent Valuation 
    13.7     Analysis by Key Players
14    Grants Analysis
    14.1     Analysis by Year
    14.2     Analysis by Amount Awarded
    14.3     Analysis by Issuing Authority
    14.4     Analysis by Grant Application
    14.5     Analysis by Funding Institute
    14.6     Analysis by Departments
    14.7     Analysis by Recipient Organization 
15    Funding and Investment Analysis
    15.1     Analysis by Funding Instances
    15.2     Analysis by Type of Funding
    15.3     Analysis by Funding Amount
    15.4     Analysis by Leading Players
    15.5     Analysis by Leading Investors
    15.6     Analysis by Geography
16    Partnership and Collaborations Analysis
    16.1     Analysis by Partnership Instances
    16.2     Analysis by Type of Partnership
    16.3     Analysis by Leading Players
    16.4     Analysis by Geography
17    Supplier Landscape
    17.1    Market Share by Top 5 Companies 
    17.2    Medtronic PLC
        17.2.1    Financial Analysis
        17.2.2    Product Portfolio
        17.2.3    Demographic Reach and Achievements
        17.2.4    Mergers and Acquisitions
        17.2.5    Certifications 
    17.3    LivaNova PLC
        17.3.1    Financial Analysis
        17.3.2    Product Portfolio
        17.3.3    Demographic Reach and Achievements
        17.3.4    Mergers and Acquisitions
        17.3.5    Certifications
    17.4    MAQUET Holding B.V. & Co. KG. 
        17.4.1    Financial Analysis
        17.4.2    Product Portfolio
        17.4.3    Demographic Reach and Achievements
        17.4.4    Mergers and Acquisitions
        17.4.5    Certifications
    17.5    Terumo Corporation
        17.5.1    Financial Analysis
        17.5.2    Product Portfolio
        17.5.3    Demographic Reach and Achievements
        17.5.4    Mergers and Acquisitions
        17.5.5    Certifications
    17.6    Braile Biomedica Ltd
        17.6.1    Financial Analysis
        17.6.2    Product Portfolio
        17.6.3    Demographic Reach and Achievements
        17.6.4    Mergers and Acquisitions
        17.6.5    Certifications
    17.7    Tianjin Medical
        17.7.1    Financial Analysis
        17.7.2    Product Portfolio
        17.7.3    Demographic Reach and Achievements
        17.7.4    Mergers and Acquisitions
        17.7.5    Certifications
    17.8    Senko Medical Instrument Manufacturing Co. Ltd.
        17.8.1    Financial Analysis
        17.8.2    Product Portfolio
        17.8.3    Demographic Reach and Achievements
        17.8.4    Mergers and Acquisitions
        17.8.5    Certifications
    17.9    Abbott 
        17.9.1    Financial Analysis
        17.9.2    Product Portfolio
        17.9.3    Demographic Reach and Achievements
        17.9.4    Mergers and Acquisitions
        17.9.5    Certifications
    17.10    Becton, Dickinson and Company 
        17.10.1    Financial Analysis
        17.10.2    Product Portfolio
        17.10.3    Demographic Reach and Achievements
        17.10.4    Mergers and Acquisitions
        17.10.5    Certifications
    17.11    Beijing ZKSK Technology Co., Ltd. 
        17.11.1    Financial Analysis
        17.11.2    Product Portfolio
        17.11.3    Demographic Reach and Achievements
        17.11.4    Mergers and Acquisitions
        17.11.5    Certifications
    17.12    Nipro Corporation
        17.12.1    Financial Analysis
        17.12.2    Product Portfolio
        17.12.3    Demographic Reach and Achievements
        17.12.4    Mergers and Acquisitions
        17.12.5    Certifications 
    17.13    MicroPort Scientific Corporation 
        17.13.1    Financial Analysis
        17.13.2    Product Portfolio
        17.13.3    Demographic Reach and Achievements
        17.13.4    Mergers and Acquisitions
        17.13.5    Certifications 
    17.14    Precision Medical, Inc. 
        17.14.1    Financial Analysis
        17.14.2    Product Portfolio
        17.14.3    Demographic Reach and Achievements
        17.14.4    Mergers and Acquisitions
        17.14.5    Certifications
    17.15    Zimmer Biomet Holdings, Inc.  
        17.15.1    Financial Analysis
        17.15.2    Product Portfolio
        17.15.3    Demographic Reach and Achievements
        17.15.4    Mergers and Acquisitions
        17.15.5    Certifications
    17.16    Technowood Corporation
        17.16.1    Financial Analysis
        17.16.2    Product Portfolio
        17.16.3    Demographic Reach and Achievements
        17.16.4    Mergers and Acquisitions
        17.16.5    Certifications 
18    Global Cardiopulmonary Bypass Equipment Market – Distribution Model (Additional Insight)
    18.1     Overview 
    18.2     Potential Distributors 
    18.3     Key Parameters for Distribution Partner Assessment 
19    Key Opinion Leaders (KOL) Insights (Additional Insight)
20    Company  Competitiveness Analysis (Additional Insight)

    20.1     Very Small Companies
    20.2     Small Companies
    20.3     Mid-Sized Companies
    20.4     Large Companies
    20.5     Very Large Companies
21    Payment Methods (Additional Insight)
    21.1     Government Funded
    21.2     Private Insurance
    21.3     Out-of-Pocket

 

*Additional insights provided are customisable as per client requirements.

 

* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.

Purchase Full Report

Mini Report

$ 2969     $2699
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5499     $4999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 6599     $5999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 7699     $6999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER